We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




New CT Imaging Protocols Improve Liver Lesion Diagnoses

By HospiMedica International staff writers
Posted on 03 Jan 2017
Researchers in Germany have shown that new dual-contrast Computed Tomography (CT) imaging protocols can improve the diagnosis of liver diseases while at the same time reducing radiation dose.

In the new technique the researchers simultaneously administered an iodine contrast agent for the arterial phase, and a gadolinium agent for the venous phase of the liver, and then used a modality called Spectral Photon Counting CT (SPCCT) to simultaneously assess the agent enhancement in the liver in various contrast phases.

The new technique was presented at the annual Radiological Society of North America (RSNA 2016) meeting by researchers from the Technical University Munich (Munich, Germany). More...
The new protocols could enable clinicians to differentiate hemangioma and other liver abnormalities from Hepato-Cellular Carcinoma (HCC), for example, and spare patients with only small benign liver lesions, from undergoing unnecessary and expensive procedures.

The Results showed that by using SPCCT and an optimized contrast injection protocol, it was possible to provide contrast-enhanced images in a single CT scan, reducing radiation dose. The scan showed both arterial gadolinium distribution, and the portal-venous phase of iodine. The liver lesions, as well as the arterial and portal-venous contrast enhancement patterns were also visible in the scan. According to the researchers, the new technique eliminates mistaken registration of artifacts between acquisitions.

Daniela Muenzel, MD, Laboratory for Advanced Computed Tomography Imaging, Technical University of Munich, said, "This multi-phase visualization of the liver at one time point by a single CT scan exhibits perfect co-registration of the images in different phases, allowing for more accurate and quantitative subsequent voxel-by-voxel post processing and a significant reduction in radiation dose. By using two contrast agents and different uptake characteristics in liver lesions, we can classify cysts, hemangiomas, HCC and metastases in a single CT scan.

Related Links:
Technical University Munich



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
X-Ray Meter
Cobia SENSE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.